Stryker Corp
NYSE:SYK
Stryker Corp
Cash from Financing Activities
Stryker Corp
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Financing Activities
-$711m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-24%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Stryker Corp's Cash from Financing Activities?
Cash from Financing Activities
-1.5B
USD
Based on the financial report for Mar 31, 2024, Stryker Corp's Cash from Financing Activities amounts to -1.5B USD.
What is Stryker Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-25%
Over the last year, the Cash from Financing Activities growth was 31%. The average annual Cash from Financing Activities growth rates for Stryker Corp have been -73% over the past three years , -15% over the past five years , and -25% over the past ten years .